MAGNESIUM CARBONATE

MAGNESIUM CARBONATE was reported 6867 times

MAGNESIUM CARBONATE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTACID THERAPY 41 0.3154
1 VAGINAL FLATULENCE 92 0.3036
2 SLEEP DISORDER THERAPY 57 0.2879
3 CONGENITAL HIATUS HERNIA 44 0.1930
4 ANALGESIC THERAPY 56 0.1745
5 MALIGNANT MELANOMA STAGE 0 35 0.1675
6 APPENDICOLITH 62 0.1602
7 DRUG THERAPY 53 0.1563
8 ANTICOAGULANT THERAPY 40 0.1408
9 SINUS POLYP DEGENERATION 2 0.0690
10 GLOMERULAR FILTRATION RATE 5 0.0685
11 BACTEROIDES INFECTION 17 0.0651
12 SWOLLEN JOINT COUNT 14 0.0560
13 FEMALE GENITAL TRACT FISTULA 94 0.0550
14 VIRURIA 5 0.0463
15 BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC 38 0.0410
16 CARDIOVASCULAR FUNCTION TEST ABNORMAL 1 0.0370
17 CARBUNCLE 10 0.0353
18 RADICULOPATHY 92 0.0349
19 HYPERPHOSPHATAEMIA 74 0.0344
20 PROCTITIS 92 0.0328
21 JUGULAR VEIN OCCLUSION 2 0.0308
22 ANISOMASTIA 1 0.0294
23 HYPOCHOLESTEROLAEMIA 9 0.0255
24 CHRONIC SINUSITIS 95 0.0253
25 TENDER JOINT COUNT 2 0.0238
26 LUPUS VULGARIS 30 0.0238
27 MITOCHONDRIAL DNA MUTATION 2 0.0233
28 BLOOD PHOSPHORUS INCREASED 60 0.0220
29 OEDEMA DUE TO CARDIAC DISEASE 3 0.0214
30 IRREGULAR SLEEP PHASE 4 0.0189
31 ADMINISTRATION SITE NODULE 1 0.0167
32 SWOLLEN JOINT COUNT INCREASED 51 0.0160
33 CSF OLIGOCLONAL BAND PRESENT 2 0.0154
34 BARTONELLOSIS 1 0.0152
35 WRIST DEFORMITY 9 0.0146
36 TOTAL LUNG CAPACITY DECREASED 23 0.0144
37 ACQUIRED PORPHYRIA 1 0.0141
38 FACET JOINT SYNDROME 44 0.0135
39 DEEP VEIN THROMBOSIS POSTOPERATIVE 27 0.0135
40 HEPATIC ENZYME 2 0.0134
41 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 68 0.0134
42 COLORECTAL ADENOCARCINOMA 3 0.0134
43 MONOCLONAL IMMUNOGLOBULIN PRESENT 10 0.0132
44 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 7 0.0125
45 PLEURITIC PAIN 34 0.0123
46 PNEUMONIA PARAINFLUENZAE VIRAL 2 0.0118
47 RESPIRATORY SYMPTOM 33 0.0116
48 BASE EXCESS INCREASED 1 0.0112
49 BLEPHAROSPASM 69 0.0109
50 URINARY SEDIMENT PRESENT 7 0.0109
51 C-REACTIVE PROTEIN 10 0.0108
52 IRON DEFICIENCY 48 0.0107
53 HYPOPHOSPHATAEMIA 78 0.0105
54 MYASTHENIA GRAVIS 84 0.0104
55 RHEUMATIC FEVER 46 0.0103
56 BLOOD URIC ACID INCREASED 59 0.0102
57 CORNEAL OPERATION 1 0.0097
58 X-RAY ABNORMAL 17 0.0095
59 PERICARDITIS CONSTRICTIVE 4 0.0095
60 VAGINAL DISCHARGE 92 0.0091
61 DUODENAL ULCER PERFORATION 64 0.0086
62 SCROTAL OEDEMA 6 0.0084
63 CARCINOID TUMOUR OF THE GASTROINTESTINAL TRACT 1 0.0084
64 ANGIODYSPLASIA 3 0.0082
65 MACULAR DEGENERATION 98 0.0082
66 ILEITIS 3 0.0078
67 HYPERCHOLESTEROLAEMIA 75 0.0078
68 RHEUMATOID FACTOR POSITIVE 44 0.0076
69 INTESTINAL MALROTATION 2 0.0076
70 ASPIRATION BONE MARROW 1 0.0075
71 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 5 0.0075
72 ABDOMINAL WALL INFECTION 1 0.0075
73 BENIGN PROSTATIC HYPERPLASIA 38 0.0074
74 PERIPHERAL VENOUS DISEASE 30 0.0073
75 LUNG OPACITY 19 0.0072
76 AORTIC STENOSIS 25 0.0072
77 ORAL CANDIDIASIS 93 0.0071
78 MUSCLE INJURY 57 0.0069
79 HYPOTHALAMO-PITUITARY DISORDER 10 0.0069
80 APPENDICITIS 63 0.0067
81 BREATH SOUNDS ABNORMAL 33 0.0067
82 CATARRH 6 0.0066
83 PARAESTHESIA ORAL 95 0.0066
84 TROPONIN INCREASED 49 0.0064
85 INFUSION SITE REACTION 19 0.0064
86 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 13 0.0063
87 LIVE BIRTH 52 0.0062
88 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 44 0.0061
89 VENTRICULAR FIBRILLATION 64 0.0058
90 BRONCHIOLITIS OBLITERANS SYNDROME 1 0.0057
91 BLOOD CALCIUM INCREASED 50 0.0057
92 STEROID DEPENDENCE 5 0.0057
93 DISLOCATION OF VERTEBRA 13 0.0057
94 WOUND INFECTION 62 0.0057
95 GLOMERULAR FILTRATION RATE ABNORMAL 8 0.0056
96 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 94 0.0055
97 MILK ALLERGY 3 0.0054
98 ADMINISTRATION SITE DISCOMFORT 1 0.0053
99 BREAST CANCER STAGE III 33 0.0051
100 MUCOSAL DISORDER 5 0.0050
101 ONYCHOMADESIS 21 0.0050
102 HELICOBACTER INFECTION 50 0.0049
103 ADRENOMEGALY 1 0.0048
104 DISSEMINATED CYTOMEGALOVIRAL INFECTION 1 0.0046
105 RETINITIS 8 0.0046
106 HYPERLIPIDAEMIA 55 0.0046
107 FOLLICULITIS 48 0.0046
108 JOINT RANGE OF MOTION DECREASED 58 0.0043
109 PROTHROMBIN TIME SHORTENED 6 0.0043
110 SYNOVITIS 77 0.0043
111 PROTHROMBIN LEVEL DECREASED 4 0.0043
112 ANORECTAL OPERATION 1 0.0042
113 PORPHYRIA ACUTE 6 0.0042
114 BACTERIAL INFECTION 78 0.0042
115 PEMPHIGUS 51 0.0041
116 CARDIOGENIC SHOCK 57 0.0040
117 PATELLOFEMORAL PAIN SYNDROME 2 0.0039
118 ULCER HAEMORRHAGE 26 0.0038
119 BETA 2 MICROGLOBULIN INCREASED 1 0.0038
120 MILK-ALKALI SYNDROME 2 0.0038
121 HAND DEFORMITY 50 0.0038
122 FREQUENT BOWEL MOVEMENTS 102 0.0038
123 VITAMIN B12 INCREASED 3 0.0038
124 WHITE BLOOD CELLS URINE POSITIVE 7 0.0037
125 BLOOD GASES ABNORMAL 2 0.0037
126 ASPIRATION 40 0.0036
127 BLOOD TEST ABNORMAL 51 0.0036
128 VIRAEMIA 5 0.0036
129 C-REACTIVE PROTEIN ABNORMAL 23 0.0036
130 NEURALGIA 87 0.0036
131 DRUG TOLERANCE 18 0.0036
132 ULCER 56 0.0035
133 EXOSTOSIS 32 0.0035
134 PLEOCYTOSIS 2 0.0034
135 TASTE DISORDER 69 0.0034
136 SCIATICA 54 0.0034
137 GOUT 60 0.0033
138 SPONDYLOARTHROPATHY 2 0.0033
139 URINARY TRACT INFECTION PSEUDOMONAL 2 0.0033
140 SACRAL PAIN 2 0.0033
141 PERICARDITIS 55 0.0033
142 FIBROSIS 10 0.0032
143 END STAGE RENAL DISEASE 59 0.0032
144 FULL BLOOD COUNT ABNORMAL 34 0.0032
145 DRUG TOLERANCE DECREASED 9 0.0032
146 MICTURITION URGENCY 36 0.0031
147 BACTERIAL TEST POSITIVE 7 0.0031
148 ANTICOAGULATION DRUG LEVEL INCREASED 1 0.0031
149 DEVICE RELATED THROMBOSIS 3 0.0030
150 MULTIPLE ORGAN DYSFUNCTION SYNDROME 84 0.0030
151 STENOTROPHOMONAS INFECTION 4 0.0029
152 BURSITIS 35 0.0029
153 ASTHMA EXERCISE INDUCED 1 0.0029
154 LOWER LIMB FRACTURE 55 0.0029
155 OVERLAP SYNDROME 2 0.0029
156 BURNS SECOND DEGREE 5 0.0028
157 FUNGAL OESOPHAGITIS 2 0.0028
158 PROPOFOL INFUSION SYNDROME 2 0.0028
159 JAUNDICE CHOLESTATIC 10 0.0028
160 MYOFASCIAL PAIN SYNDROME 2 0.0028
161 PROCEDURAL PAIN 78 0.0028
162 EPILEPSY 85 0.0028
163 ANTIBODY TEST ABNORMAL 2 0.0028
164 PRESCRIBED OVERDOSE 53 0.0027
165 DIET NONCOMPLIANCE 1 0.0027
166 COLITIS 102 0.0027
167 GINGIVAL ULCERATION 2 0.0027
168 MULTIPLE DRUG THERAPY 2 0.0027
169 DIABETIC KETOSIS 1 0.0026
170 HAEMATOCRIT INCREASED 6 0.0026
171 SERONEGATIVE ARTHRITIS 3 0.0026
172 JOINT DESTRUCTION 4 0.0026
173 METAPNEUMOVIRUS INFECTION 2 0.0026
174 LIP DRY 23 0.0025
175 METABOLIC ALKALOSIS 4 0.0025
176 DISEASE RISK FACTOR 1 0.0025
177 FINGER DEFORMITY 12 0.0025
178 MALIGNANT MELANOMA IN SITU 3 0.0024
179 RECTAL HAEMORRHAGE 103 0.0024
180 COLITIS ULCERATIVE 106 0.0024
181 ALVEOLAR OSTEITIS 1 0.0024
182 PRESCRIBED UNDERDOSE 47 0.0024
183 BONE SCAN ABNORMAL 1 0.0024
184 IRRITABLE BOWEL SYNDROME 50 0.0023
185 WALKING AID USER 15 0.0023
186 BONE EROSION 8 0.0023
187 RALES 13 0.0022
188 PRIMARY SEQUESTRUM 2 0.0022
189 CORONARY ANGIOPLASTY 1 0.0022
190 BLOOD CHOLESTEROL INCREASED 102 0.0022
191 ASCITES 64 0.0022
192 RED BLOOD CELL SEDIMENTATION RATE INCREASED 24 0.0022
193 DYSLIPIDAEMIA 11 0.0022
194 INFUSION RELATED REACTION 142 0.0021
195 BACK INJURY 23 0.0021
196 WOUND 59 0.0021
197 BLOOD CHOLESTEROL 1 0.0021
198 BRONCHIECTASIS 14 0.0021
199 NAIL DISORDER 18 0.0021
200 BLOOD CREATININE ABNORMAL 7 0.0020
201 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 13 0.0020
202 LOWER RESPIRATORY TRACT INFECTION 91 0.0020
203 SLEEP DISORDER 140 0.0020
204 TRANSAMINASES INCREASED 44 0.0020
205 PLEURAL FIBROSIS 2 0.0020
206 RENAL FUNCTION TEST ABNORMAL 9 0.0019
207 FIBROMYALGIA 47 0.0019
208 BODY TEMPERATURE FLUCTUATION 4 0.0019
209 EXERCISE TOLERANCE DECREASED 11 0.0019
210 SYSTEMIC LUPUS ERYTHEMATOSUS 67 0.0019
211 ALCOHOL POISONING 5 0.0019
212 OVERWEIGHT 10 0.0019
213 GLOSSODYNIA 41 0.0018
214 BLOOD INSULIN INCREASED 1 0.0018
215 HAEMATOCHEZIA 99 0.0018
216 DRUG INTOLERANCE 173 0.0018
217 TYPE 2 DIABETES MELLITUS 60 0.0018
218 GASTRIC POLYPS 4 0.0018
219 LUPUS-LIKE SYNDROME 16 0.0018
220 SWELLING 165 0.0018
221 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 124 0.0017
222 SENSITIVITY OF TEETH 3 0.0017
223 JOINT INJURY 37 0.0017
224 DEVICE MAINTENANCE ISSUE 1 0.0017
225 EAR PAIN 33 0.0017
226 CAMPYLOBACTER GASTROENTERITIS 1 0.0017
227 HYPONATRAEMIA 95 0.0017
228 BICUSPID AORTIC VALVE 1 0.0017
229 IMMUNOSUPPRESSANT DRUG LEVEL DECREASED 2 0.0017
230 IMPAIRED HEALING 51 0.0016
231 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 1 0.0015
232 CONTRAINDICATED PRODUCT ADMINISTERED 46 0.0015
233 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 79 0.0015
234 RENAL CYST 12 0.0015
235 PROTHROMBIN TIME PROLONGED 9 0.0015
236 WHEEZING 88 0.0015
237 GRIP STRENGTH DECREASED 13 0.0015
238 PUSTULAR PSORIASIS 5 0.0015
239 RED CELL DISTRIBUTION WIDTH INCREASED 6 0.0014
240 HYPOPNOEA 5 0.0014
241 AUTOIMMUNE DISORDER 14 0.0014
242 DRY MOUTH 116 0.0014
243 DILATATION VENTRICULAR 3 0.0014
244 LIVER INJURY 35 0.0014
245 BRONCHIOLITIS 5 0.0014
246 DERMATITIS DIAPER 1 0.0014
247 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 3 0.0014
248 IRON DEFICIENCY ANAEMIA 13 0.0014
249 THERAPEUTIC PRODUCT EFFECT DECREASED 63 0.0014
250 GAIT INABILITY 46 0.0014
251 LIVER DISORDER 61 0.0014
252 SPONDYLITIS 5 0.0014
253 GRAFT VERSUS HOST DISEASE IN SKIN 3 0.0014
254 PSORIATIC ARTHROPATHY 55 0.0014
255 FOOT DEFORMITY 15 0.0014
256 ARTERIAL INJURY 1 0.0013
257 CREATININE RENAL CLEARANCE INCREASED 1 0.0013
258 OBESITY 21 0.0013
259 EYE INJURY 4 0.0013
260 HAEMOGLOBIN INCREASED 6 0.0013
261 LIVER FUNCTION TEST INCREASED 28 0.0013
262 PULMONARY FIBROSIS 25 0.0013
263 CALCULUS URINARY 2 0.0013
264 CARDIOVASCULAR DISORDER 33 0.0013
265 LUNG DISORDER 63 0.0013
266 DIABETES MELLITUS 97 0.0013
267 BLOOD FIBRINOGEN INCREASED 1 0.0013
268 GASTROOESOPHAGEAL REFLUX DISEASE 101 0.0013
269 PNEUMONIA LEGIONELLA 2 0.0012
270 PURPURA 11 0.0012
271 RASH VESICULAR 6 0.0012
272 C-REACTIVE PROTEIN INCREASED 45 0.0012
273 CORONARY ARTERY DISEASE 37 0.0012
274 ADRENAL MASS 1 0.0012
275 BREAST CANCER STAGE II 10 0.0012
276 VENOOCCLUSIVE DISEASE 3 0.0012
277 GENERAL PHYSICAL HEALTH DETERIORATION 138 0.0012
278 DENTAL DISCOMFORT 1 0.0012
279 OSTEOARTHRITIS 50 0.0012
280 DYSPEPSIA 116 0.0012
281 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 20 0.0012
282 SEDATION COMPLICATION 3 0.0012
283 ABSCESS DRAINAGE 1 0.0012
284 BLOOD CREATINE INCREASED 5 0.0011
285 CANDIDA SEPSIS 1 0.0011
286 VOCAL CORD PARALYSIS 2 0.0011
287 BLOOD MAGNESIUM INCREASED 1 0.0011
288 ESSENTIAL HYPERTENSION 2 0.0011
289 IMMUNE THROMBOCYTOPENIA 5 0.0011
290 NIGHT SWEATS 35 0.0011
291 ADENOCARCINOMA GASTRIC 1 0.0011
292 NEPHROPATHY 10 0.0011
293 HEPATIC CIRRHOSIS 20 0.0011
294 ARTHROPATHY 59 0.0011
295 SACROILIITIS 2 0.0011
296 SPUTUM DISCOLOURED 10 0.0011
297 OSTEOPOROTIC FRACTURE 2 0.0010
298 ANAEMIA 198 0.0010
299 THROMBOSIS 83 0.0010
300 JOINT STIFFNESS 27 0.0010
301 ANIMAL SCRATCH 1 0.0010
302 PURULENCE 2 0.0010
303 BLOOD IRON ABNORMAL 1 0.0010
304 GENE MUTATION 2 0.0010
305 TRANSIENT ISCHAEMIC ATTACK 34 0.0010
306 MUSCULOSKELETAL STIFFNESS 88 0.0010
307 DILATED CARDIOMYOPATHY 1 0.0010
308 RENAL MASS 2 0.0010
309 NEUROGENIC BLADDER 2 0.0009
310 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 1 0.0009
311 FEBRILE BONE MARROW APLASIA 4 0.0009
312 BODY HEIGHT DECREASED 10 0.0009
313 PRODUCT DISPENSING ISSUE 4 0.0009
314 BLOOD CREATININE INCREASED 61 0.0009
315 MIGRAINE 89 0.0009
316 PAROSMIA 7 0.0009
317 PULMONARY EMBOLISM 88 0.0009
318 VITREOUS DETACHMENT 2 0.0009
319 NORMAL NEWBORN 5 0.0009
320 INTENTIONAL PRODUCT MISUSE 80 0.0009
321 CONGENITAL ANOMALY 7 0.0009
322 AORTIC DILATATION 1 0.0009
323 CHRONIC GASTRITIS 2 0.0009
324 COMPUTERISED TOMOGRAM ABNORMAL 2 0.0009
325 STOMATITIS 53 0.0009
326 DIFFUSE ALVEOLAR DAMAGE 1 0.0009
327 RED BLOOD CELL SEDIMENTATION RATE ABNORMAL 2 0.0009
328 AORTIC THROMBOSIS 1 0.0009
329 UPPER RESPIRATORY TRACT INFECTION 40 0.0009
330 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
331 SINUS PAIN 2 0.0009
332 BLISTER 48 0.0009
333 MATERNAL EXPOSURE DURING PREGNANCY 76 0.0009
334 BONE MARROW TOXICITY 1 0.0008
335 ABDOMINAL DISTENSION 88 0.0008
336 PNEUMONIA ASPIRATION 21 0.0008
337 RESPIRATORY DISORDER 25 0.0008
338 ABDOMINAL PAIN 193 0.0008
339 CHRONIC RESPIRATORY FAILURE 1 0.0008
340 SEPSIS 92 0.0008
341 BLOOD ELECTROLYTES ABNORMAL 1 0.0008
342 AMPUTATION 1 0.0008
343 THERAPY NON-RESPONDER 36 0.0008
344 CONSTIPATION 173 0.0008
345 HEPATIC ENZYME INCREASED 54 0.0008
346 BAND SENSATION 1 0.0008
347 GINGIVAL DISORDER 3 0.0008
348 RHINOVIRUS INFECTION 3 0.0008
349 BLOOD THYROID STIMULATING HORMONE INCREASED 7 0.0008
350 POLYARTHRITIS 4 0.0008
351 ATRIAL FLUTTER 6 0.0008
352 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
353 HYPOAESTHESIA 112 0.0007
354 INTENTIONAL PRODUCT USE ISSUE 65 0.0007
355 MOBILITY DECREASED 53 0.0007
356 TREATMENT FAILURE 61 0.0007
357 STOMA SITE DISCHARGE 2 0.0007
358 HYPERURICAEMIA 3 0.0007
359 MUSCULOSKELETAL PAIN 38 0.0007
360 DELIRIUM 25 0.0007
361 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
362 LEUKOCYTOSIS 13 0.0007
363 CHRONIC FATIGUE SYNDROME 1 0.0007
364 CATAPLEXY 1 0.0007
365 APPENDIX DISORDER 1 0.0007
366 BLOOD ELECTROLYTES DECREASED 1 0.0007
367 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
368 CARDIAC MURMUR 6 0.0007
369 ESCHERICHIA SEPSIS 2 0.0007
370 ASTHMA 78 0.0007
371 PULMONARY PAIN 2 0.0007
372 DARK CIRCLES UNDER EYES 1 0.0007
373 OEDEMA PERIPHERAL 81 0.0007
374 SUSPECTED OFF LABEL USE 3 0.0007
375 RHEUMATOID ARTHRITIS 75 0.0007
376 HIP ARTHROPLASTY 10 0.0007
377 ISCHAEMIC CARDIOMYOPATHY 2 0.0007
378 MULTIPLE-DRUG RESISTANCE 2 0.0006
379 PERFORMANCE STATUS DECREASED 3 0.0006
380 INFLAMMATION 33 0.0006
381 BREAST CANCER RECURRENT 2 0.0006
382 BLADDER PAIN 2 0.0006
383 GINGIVAL PAIN 5 0.0006
384 GASTROINTESTINAL DISORDER 56 0.0006
385 RHINITIS 5 0.0006
386 MEMORY IMPAIRMENT 85 0.0006
387 SOMNOLENCE 124 0.0006
388 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
389 LYMPHOCYTE COUNT INCREASED 2 0.0006
390 COLONIC POLYP 1 0.0006
391 DRUG-INDUCED LIVER INJURY 19 0.0006
392 PARAESTHESIA 95 0.0006
393 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 29 0.0006
394 ANXIETY DISORDER 2 0.0006
395 PLANTAR FASCIITIS 2 0.0006
396 BLOOD BILIRUBIN INCREASED 16 0.0006
397 HEPATIC STEATOSIS 11 0.0006
398 DISCOMFORT 36 0.0006
399 HEPATIC CYST 2 0.0006
400 ACUTE SINUSITIS 1 0.0006
401 HYPERBILIRUBINAEMIA 6 0.0006
402 PYELONEPHRITIS 5 0.0006
403 HYPERTRANSAMINASAEMIA 4 0.0006
404 WEIGHT FLUCTUATION 6 0.0006
405 CAROTID ARTERY STENOSIS 2 0.0006
406 JOINT DISLOCATION 6 0.0006
407 ASPARTATE AMINOTRANSFERASE INCREASED 30 0.0006
408 HYPERTENSION 119 0.0006
409 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
410 AORTIC VALVE STENOSIS 1 0.0006
411 INJURY 39 0.0006
412 RENAL TRANSPLANT 2 0.0006
413 OEDEMA 30 0.0006
414 MONOCYTE COUNT INCREASED 2 0.0006
415 CUTANEOUS VASCULITIS 2 0.0005
416 THROMBOCYTOSIS 2 0.0005
417 BODY TEMPERATURE ABNORMAL 1 0.0005
418 DENTAL CARE 1 0.0005
419 PERSONALITY CHANGE 5 0.0005
420 BLOOD IRON INCREASED 1 0.0005
421 SNORING 2 0.0005
422 THERAPEUTIC RESPONSE DECREASED 32 0.0005
423 CLAVICLE FRACTURE 2 0.0005
424 RASH PRURITIC 28 0.0005
425 PRODUCT LABEL CONFUSION 3 0.0005
426 CARDIOPULMONARY FAILURE 2 0.0005
427 CYTOMEGALOVIRUS CHORIORETINITIS 1 0.0005
428 PRODUCT USE IN UNAPPROVED INDICATION 127 0.0005
429 ABDOMINAL PAIN UPPER 105 0.0005
430 PLEURAL EFFUSION 31 0.0005
431 ERYTHEMA 104 0.0005
432 CONDITION AGGRAVATED 153 0.0005
433 ANORECTAL DISORDER 1 0.0005
434 NECK PAIN 28 0.0005
435 BLOOD POTASSIUM DECREASED 15 0.0005
436 CORONARY ARTERY THROMBOSIS 1 0.0005
437 ADRENAL INSUFFICIENCY 6 0.0005
438 PYREXIA 171 0.0005
439 SELF-MEDICATION 2 0.0005
440 OSTEOPOROSIS 20 0.0005
441 DIVERTICULAR PERFORATION 1 0.0005
442 SPINAL STENOSIS 2 0.0005
443 BLOOD ALKALINE PHOSPHATASE INCREASED 12 0.0005
444 CHEST INJURY 1 0.0005
445 PRE-EXISTING CONDITION IMPROVED 3 0.0005
446 EOSINOPHIL COUNT INCREASED 4 0.0005
447 ROAD TRAFFIC ACCIDENT 20 0.0005
448 DEVICE MATERIAL ISSUE 1 0.0005
449 DEVICE CONNECTION ISSUE 1 0.0005
450 PULMONARY MASS 7 0.0005
451 POOR PERIPHERAL CIRCULATION 2 0.0005
452 MOVEMENT DISORDER 15 0.0005
453 HAEMOPTYSIS 13 0.0005
454 WEIGHT DECREASED 130 0.0005
455 DEREALISATION 1 0.0005
456 ATRIOVENTRICULAR BLOCK FIRST DEGREE 2 0.0005
457 FAECES DISCOLOURED 10 0.0005
458 TOOTH INJURY 2 0.0005
459 STAPHYLOCOCCAL BACTERAEMIA 2 0.0005
460 BONE CANCER 2 0.0005
461 ONYCHOMYCOSIS 2 0.0005
462 GAMMA-GLUTAMYLTRANSFERASE INCREASED 10 0.0005
463 VOMITING 212 0.0005
464 RESPIRATORY RATE INCREASED 4 0.0005
465 ADENOCARCINOMA 1 0.0004
466 MYOSITIS 4 0.0004
467 HEAVY MENSTRUAL BLEEDING 4 0.0004
468 LIMB INJURY 12 0.0004
469 VASCULAR DEVICE INFECTION 2 0.0004
470 THERAPEUTIC PRODUCT EFFECT DELAYED 2 0.0004
471 KNEE ARTHROPLASTY 9 0.0004
472 DIVERTICULUM 3 0.0004
473 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
474 SKIN DISORDER 14 0.0004
475 SINUSITIS 43 0.0004
476 OFF LABEL USE 364 0.0004
477 DIABETES INSIPIDUS 1 0.0004
478 JOINT SWELLING 50 0.0004
479 BLOOD IMMUNOGLOBULIN E INCREASED 1 0.0004
480 HYPOKALAEMIA 19 0.0004
481 CIRCULATORY COLLAPSE 7 0.0004
482 DYSSTASIA 12 0.0004
483 ORAL DISORDER 3 0.0004
484 PAIN 250 0.0004
485 IMMUNODEFICIENCY 6 0.0004
486 MALAISE 174 0.0004
487 PERITONITIS BACTERIAL 4 0.0004
488 CHOLELITHIASIS 13 0.0004
489 ABDOMINAL DISCOMFORT 65 0.0004
490 APHTHOUS ULCER 3 0.0004
491 POOR VENOUS ACCESS 4 0.0004
492 PARTIAL SEIZURES 2 0.0004
493 BLOOD LACTIC ACID INCREASED 2 0.0004
494 TRICUSPID VALVE INCOMPETENCE 3 0.0004
495 CONFUSIONAL STATE 61 0.0004
496 EAR INFECTION 10 0.0004
497 ANIMAL BITE 1 0.0004
498 TUBULOINTERSTITIAL NEPHRITIS 7 0.0004
499 NASOPHARYNGITIS 68 0.0004
500 PROTEINURIA 7 0.0004
501 CLUMSINESS 1 0.0004
502 CLOSTRIDIUM DIFFICILE INFECTION 8 0.0004
503 ILL-DEFINED DISORDER 22 0.0004
504 NECROSIS 2 0.0004
505 COMA 17 0.0004
506 COLECTOMY 2 0.0004
507 DISABILITY 7 0.0004
508 PERIORBITAL SWELLING 2 0.0004
509 URTICARIA 59 0.0004
510 PRODUCT USE ISSUE 66 0.0004
511 BONE DENSITY DECREASED 11 0.0004
512 PERIPHERAL SWELLING 54 0.0004
513 IMPAIRED QUALITY OF LIFE 5 0.0003
514 ASTHENIA 130 0.0003
515 PULMONARY ARTERIAL HYPERTENSION 5 0.0003
516 ORTHOSTATIC HYPOTENSION 6 0.0003
517 COMPLICATION ASSOCIATED WITH DEVICE 5 0.0003
518 IMMUNOSUPPRESSION 3 0.0003
519 NAUSEA 269 0.0003
520 LUNG INFILTRATION 3 0.0003
521 GASTROINTESTINAL INFECTION 3 0.0003
522 WRIST FRACTURE 4 0.0003
523 RESTLESS LEGS SYNDROME 6 0.0003
524 ATRIOVENTRICULAR BLOCK SECOND DEGREE 1 0.0003
525 HEADACHE 205 0.0003
526 OLIGURIA 2 0.0003
527 SWOLLEN TONGUE 10 0.0003
528 INFUSION SITE SWELLING 2 0.0003
529 TOOTH DISORDER 7 0.0003
530 HEPATIC CYTOLYSIS 4 0.0003
531 ENTERITIS 2 0.0003
532 PROCTALGIA 2 0.0003
533 MUSCLE TIGHTNESS 5 0.0003
534 CHEST PAIN 57 0.0003
535 HERPES SIMPLEX 2 0.0003
536 BACTERIAL SEPSIS 1 0.0003
537 ARTHRITIS 24 0.0003
538 DYSGRAPHIA 2 0.0003
539 BLOOD PRESSURE ABNORMAL 6 0.0003
540 CONTUSION 29 0.0003
541 COAGULOPATHY 5 0.0003
542 JAUNDICE 8 0.0003
543 COLITIS ISCHAEMIC 2 0.0003
544 ALOPECIA 58 0.0003
545 CARBOHYDRATE ANTIGEN 125 INCREASED 1 0.0003
546 ADVERSE EVENT 27 0.0003
547 AUTOIMMUNE HAEMOLYTIC ANAEMIA 1 0.0003
548 MUSCULAR WEAKNESS 33 0.0003
549 ADVERSE DRUG REACTION 26 0.0003
550 LYMPHOEDEMA 2 0.0003
551 ENCEPHALITIS 2 0.0003
552 HAIR GROWTH ABNORMAL 2 0.0003
553 FORMICATION 2 0.0003
554 EOSINOPHILIA 5 0.0003
555 TREMOR 47 0.0003
556 HEPATOCELLULAR INJURY 4 0.0003
557 APPENDICECTOMY 1 0.0003
558 BREAST CANCER METASTATIC 3 0.0003
559 BONE LESION 1 0.0003
560 DEPRESSION 63 0.0003
561 VISUAL FIELD DEFECT 2 0.0003
562 TOOTHACHE 5 0.0003
563 MELAENA 6 0.0003
564 HEPATIC FUNCTION ABNORMAL 10 0.0003
565 HYDRONEPHROSIS 2 0.0003
566 GENERAL SYMPTOM 2 0.0003
567 BLOOD CALCIUM DECREASED 3 0.0003
568 MITRAL VALVE INCOMPETENCE 3 0.0003
569 CATHETER SITE INFECTION 1 0.0003
570 TENDON PAIN 2 0.0003
571 WEIGHT INCREASED 59 0.0003
572 GASTRIC ULCER 5 0.0003
573 AORTIC ANEURYSM 2 0.0003
574 NEOPLASM 3 0.0003
575 PROCEDURAL COMPLICATION 2 0.0003
576 RENAL FAILURE CHRONIC 2 0.0003
577 PRODUCT QUALITY ISSUE 35 0.0003
578 EXPOSURE DURING PREGNANCY 16 0.0003
579 BLOOD PRESSURE SYSTOLIC INCREASED 5 0.0003
580 PNEUMONIA 83 0.0003
581 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
582 BLOOD IRON DECREASED 3 0.0003
583 BLOOD ALBUMIN DECREASED 2 0.0003
584 BLOOD PRESSURE FLUCTUATION 6 0.0002
585 PREGNANCY 5 0.0002
586 TRANSPLANT REJECTION 2 0.0002
587 PAIN IN JAW 7 0.0002
588 ACCIDENTAL OVERDOSE 9 0.0002
589 BACK DISORDER 4 0.0002
590 AMNESIA 16 0.0002
591 ABNORMAL FAECES 2 0.0002
592 METASTASES TO BONE 4 0.0002
593 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
594 DYSPNOEA 137 0.0002
595 LIVER FUNCTION TEST ABNORMAL 7 0.0002
596 MUSCLE SPASMS 44 0.0002
597 BUNDLE BRANCH BLOCK LEFT 1 0.0002
598 AORTIC VALVE INCOMPETENCE 1 0.0002
599 CARDIAC FAILURE CHRONIC 1 0.0002
600 IMPAIRED WORK ABILITY 5 0.0002
601 ROTATOR CUFF SYNDROME 3 0.0002
602 PSEUDOMONAS INFECTION 2 0.0002
603 BLOOD MAGNESIUM DECREASED 2 0.0002
604 PSYCHOLOGICAL TRAUMA 2 0.0002
605 CHAPPED LIPS 1 0.0002
606 NODULE 3 0.0002
607 HYPOXIA 8 0.0002
608 COLD SWEAT 4 0.0002
609 BLOOD TRIGLYCERIDES INCREASED 4 0.0002
610 RASH 98 0.0002
611 RASH MACULO-PAPULAR 5 0.0002
612 DECREASED APPETITE 52 0.0002
613 MOOD ALTERED 6 0.0002
614 GINGIVAL BLEEDING 3 0.0002
615 GAIT DISTURBANCE 42 0.0002
616 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 12 0.0002
617 CENTRAL NERVOUS SYSTEM LESION 3 0.0002
618 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
619 FATIGUE 168 0.0002
620 ARTHRITIS INFECTIVE 1 0.0002
621 SEASONAL ALLERGY 3 0.0002
622 HYPOCALCAEMIA 4 0.0002
623 SPINAL DISORDER 2 0.0002
624 INCREASED APPETITE 4 0.0002
625 WHITE BLOOD CELL COUNT INCREASED 8 0.0002
626 LOCALISED INFECTION 5 0.0002
627 HYPOKINESIA 3 0.0002
628 DRUG INEFFECTIVE 272 0.0002
629 PRESYNCOPE 5 0.0002
630 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 37 0.0002
631 THROMBOTIC MICROANGIOPATHY 2 0.0002
632 ARTHRALGIA 85 0.0002
633 HAEMATURIA 7 0.0002
634 COELIAC DISEASE 2 0.0002
635 VITREOUS FLOATERS 2 0.0002
636 KNEE OPERATION 2 0.0002
637 BODY TEMPERATURE DECREASED 2 0.0002
638 NIGHTMARE 7 0.0002
639 SINUS DISORDER 4 0.0002
640 DIABETIC NEUROPATHY 1 0.0002
641 ABDOMINAL TENDERNESS 1 0.0002
642 COLON CANCER 3 0.0002
643 ANEURYSM 1 0.0002
644 HEART RATE DECREASED 7 0.0002
645 HEPATIC FAILURE 6 0.0002
646 DIARRHOEA 128 0.0002
647 PRODUCT ADMINISTRATION ERROR 4 0.0002
648 MEDICATION ERROR 11 0.0002
649 DRUG LEVEL DECREASED 2 0.0002
650 DRUG DELIVERY SYSTEM MALFUNCTION 1 0.0002
651 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0002
652 COGNITIVE DISORDER 9 0.0002
653 TENDERNESS 2 0.0002
654 APLASTIC ANAEMIA 1 0.0002
655 ECZEMA 10 0.0002
656 INJECTION SITE DISCOMFORT 2 0.0002
657 SUDDEN DEATH 2 0.0002
658 ABSCESS 3 0.0002
659 ANAL FISSURE 1 0.0002
660 BRUXISM 1 0.0002
661 BEHAVIOUR DISORDER 1 0.0002
662 SKIN LACERATION 2 0.0002
663 HYPERSENSITIVITY 34 0.0002
664 TOOTH FRACTURE 2 0.0002
665 DRUG LEVEL BELOW THERAPEUTIC 1 0.0002
666 ANAPHYLACTIC REACTION 10 0.0002
667 DENTAL CARIES 2 0.0002
668 VERTIGO 11 0.0002
669 PANCYTOPENIA 10 0.0002
670 NEUROPATHY PERIPHERAL 17 0.0002
671 ORAL PAIN 4 0.0002
672 UNDERDOSE 13 0.0002
673 FISTULA 2 0.0002
674 HEMIPARESIS 3 0.0002
675 STATUS EPILEPTICUS 2 0.0002
676 HEART RATE IRREGULAR 4 0.0002
677 PAIN IN EXTREMITY 52 0.0002
678 FLATULENCE 10 0.0002
679 MYOCARDIAL ISCHAEMIA 2 0.0002
680 MYOCARDITIS 2 0.0002
681 TINNITUS 8 0.0002
682 PERICARDIAL EFFUSION 4 0.0002
683 NEOPLASM PROGRESSION 6 0.0002
684 NERVOUSNESS 9 0.0002
685 SPLENOMEGALY 2 0.0002
686 SPINAL PAIN 2 0.0002
687 METASTASES TO LIVER 3 0.0002
688 PANCREATITIS 9 0.0002
689 PRODUCT DOSE OMISSION ISSUE 50 0.0002
690 BACTERAEMIA 2 0.0002
691 INFECTION 24 0.0002
692 OSTEOMYELITIS 3 0.0002
693 PRURITUS 63 0.0002
694 BRONCHITIS 12 0.0002
695 TENDON RUPTURE 2 0.0002
696 HYPERCALCAEMIA 2 0.0002
697 LEUKOPENIA 8 0.0002
698 SECRETION DISCHARGE 2 0.0002
699 DYSARTHRIA 6 0.0002
700 SLEEP APNOEA SYNDROME 3 0.0002
701 HYPOPHAGIA 4 0.0002
702 HEPATITIS 4 0.0002
703 ACUTE RESPIRATORY FAILURE 3 0.0002
704 GLAUCOMA 3 0.0002
705 HERNIA 3 0.0002
706 HIATUS HERNIA 2 0.0002
707 INSOMNIA 41 0.0002
708 THERAPY INTERRUPTED 11 0.0002
709 HAEMORRHOIDS 3 0.0002
710 SKIN FISSURES 3 0.0002
711 NASAL CONGESTION 9 0.0002
712 PSORIASIS 20 0.0002
713 MUCOSAL INFLAMMATION 4 0.0002
714 SEDATION 4 0.0002
715 GASTRITIS 4 0.0002
716 TOOTH INFECTION 2 0.0002
717 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
718 ADVERSE REACTION 2 0.0002
719 FEBRILE NEUTROPENIA 10 0.0002
720 SINUS CONGESTION 2 0.0001
721 FEEDING DISORDER 3 0.0001
722 BODY TEMPERATURE INCREASED 3 0.0001
723 IMPAIRED GASTRIC EMPTYING 2 0.0001
724 CROHN'S DISEASE 1 0.0001
725 RIB FRACTURE 3 0.0001
726 PALPITATIONS 17 0.0001
727 PERITONITIS 3 0.0001
728 DROOLING 1 0.0001
729 DIVERTICULITIS 4 0.0001
730 FALL 48 0.0001
731 BLOOD PRESSURE INCREASED 22 0.0001
732 POLLAKIURIA 6 0.0001
733 ATRIAL FIBRILLATION 14 0.0001
734 HUNGER 2 0.0001
735 CARPAL TUNNEL SYNDROME 2 0.0001
736 DISSEMINATED INTRAVASCULAR COAGULATION 2 0.0001
737 HEART RATE INCREASED 14 0.0001
738 SINUS TACHYCARDIA 2 0.0001
739 INTENTIONAL DOSE OMISSION 4 0.0001
740 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 1 0.0001
741 DEEP VEIN THROMBOSIS 9 0.0001
742 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
743 MYELODYSPLASTIC SYNDROME 2 0.0001
744 ANOSMIA 2 0.0001
745 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
746 HYPERGLYCAEMIA 5 0.0001
747 CARDIAC FAILURE 11 0.0001
748 HOSPITALISATION 21 0.0001
749 BONE PAIN 8 0.0001
750 ARTHROPOD BITE 1 0.0001
751 RASH PAPULAR 3 0.0001
752 SNEEZING 3 0.0001
753 PANCREATITIS ACUTE 3 0.0001
754 LACRIMATION INCREASED 4 0.0001
755 BLOOD COUNT ABNORMAL 2 0.0001
756 TOXIC EPIDERMAL NECROLYSIS 2 0.0001
757 INSURANCE ISSUE 2 0.0001
758 BOWEL MOVEMENT IRREGULARITY 1 0.0001
759 DIZZINESS 65 0.0001
760 ALANINE AMINOTRANSFERASE INCREASED 8 0.0001
761 OROPHARYNGEAL PAIN 12 0.0001
762 LIMB DISCOMFORT 4 0.0001
763 MUSCULOSKELETAL CHEST PAIN 2 0.0001
764 TENDONITIS 2 0.0001
765 BACK PAIN 30 0.0001
766 BRONCHOPULMONARY ASPERGILLOSIS 1 0.0001
767 EJECTION FRACTION DECREASED 2 0.0001
768 BASAL CELL CARCINOMA 2 0.0001
769 BRAIN FOG 2 0.0001
770 BALANCE DISORDER 11 0.0001
771 ARRHYTHMIA 6 0.0001
772 BLOOD LACTATE DEHYDROGENASE INCREASED 2 0.0001
773 RESPIRATORY TRACT CONGESTION 2 0.0001
774 HALLUCINATION, AUDITORY 2 0.0001
775 BLOOD DISORDER 1 0.0001
776 BLOOD POTASSIUM INCREASED 2 0.0001
777 CEREBRAL INFARCTION 3 0.0001
778 OSTEONECROSIS OF JAW 3 0.0001
779 DYSGEUSIA 9 0.0001
780 DRUG LEVEL INCREASED 2 0.0001
781 ACUTE CORONARY SYNDROME 1 0.0001
782 CYTOMEGALOVIRUS INFECTION 2 0.0001
783 LIP SWELLING 4 0.0001
784 FUNGAL INFECTION 4 0.0001
785 ANXIETY 34 0.0001
786 RENAL IMPAIRMENT 10 0.0001
787 CHRONIC KIDNEY DISEASE 9 0.0001
788 ILLNESS 12 0.0001
789 SEPTIC SHOCK 5 0.0001
790 COUGH 32 0.0001
791 COVID-19 20 0.0001
792 RENAL FAILURE 15 0.0001
793 DRUG ERUPTION 2 0.0001
794 ELECTROCARDIOGRAM QT PROLONGED 4 0.0001
795 BONE DISORDER 2 0.0001
796 NEPHROLITHIASIS 5 0.0001
797 RESPIRATORY DISTRESS 3 0.0001
798 BREAST CANCER STAGE I 1 0.0001
799 EYE SWELLING 4 0.0001
800 SWELLING FACE 7 0.0001
801 THINKING ABNORMAL 2 0.0001
802 THROMBOCYTOPENIA 12 0.0001
803 MIDDLE INSOMNIA 2 0.0001
804 DIARRHOEA HAEMORRHAGIC 1 0.0001
805 EPISTAXIS 8 0.0001
806 OXYGEN SATURATION DECREASED 6 0.0001
807 PHOTOPHOBIA 2 0.0001
808 ARTERIOSCLEROSIS 1 0.0001
809 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
810 UNEVALUABLE EVENT 8 0.0001
811 MUSCULOSKELETAL DISORDER 2 0.0001
812 RED BLOOD CELL COUNT DECREASED 3 0.0001
813 ACUTE KIDNEY INJURY 16 0.0001
814 CHOLESTASIS 2 0.0001
815 AFFECT LABILITY 1 0.0001
816 DIZZINESS POSTURAL 1 0.0001
817 SURGERY 6 0.0001
818 LABORATORY TEST ABNORMAL 3 0.0001
819 DEPRESSED LEVEL OF CONSCIOUSNESS 4 0.0001
820 HAEMATOCRIT DECREASED 2 0.0001
821 BLADDER DISORDER 1 0.0001
822 UPPER LIMB FRACTURE 2 0.0001
823 BURNING SENSATION 7 0.0001
824 DYSKINESIA 4 0.0001
825 FOETAL EXPOSURE DURING PREGNANCY 8 0.0001
826 FLUSHING 10 0.0001
827 NEUTROPHIL COUNT DECREASED 4 0.0001
828 TOOTH LOSS 2 0.0001
829 NEUTROPENIA 13 0.0001
830 HALLUCINATION, VISUAL 2 0.0001
831 RETCHING 2 0.0001
832 HYPOACUSIS 4 0.0001
833 POOR QUALITY SLEEP 2 0.0001
834 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
835 BIPOLAR DISORDER 1 0.0001
836 PRODUCT DISPENSING ERROR 2 0.0001
837 EYE DISORDER 3 0.0001
838 SYNCOPE 9 0.0001
839 URINARY RETENTION 3 0.0001
840 HYPOTENSION 18 0.0001
841 INFLUENZA 10 0.0001
842 MYALGIA 15 0.0001
843 DERMATITIS CONTACT 1 0.0001
844 CHOLECYSTECTOMY 1 0.0001
845 SKIN IRRITATION 4 0.0001
846 SHOCK 2 0.0001
847 LOSS OF CONSCIOUSNESS 11 0.0001
848 HYPERKALAEMIA 3 0.0001
849 DYSPHONIA 5 0.0001
850 ATAXIA 1 0.0001
851 DRUG ABUSE 7 0.0001
852 PRODUCTIVE COUGH 4 0.0001
853 INTERSTITIAL LUNG DISEASE 4 0.0001
854 CRYING 3 0.0001
855 RESTLESSNESS 3 0.0001
856 INJECTION SITE URTICARIA 2 0.0001
857 CARDIOMEGALY 1 0.0001
858 AGEUSIA 2 0.0001
859 PRODUCT STORAGE ERROR 7 0.0001
860 DYSPNOEA EXERTIONAL 3 0.0001
861 TACHYCARDIA 7 0.0001
862 FLUID RETENTION 4 0.0001
863 MALIGNANT NEOPLASM PROGRESSION 8 0.0001
864 HAEMOGLOBIN DECREASED 8 0.0001
865 DEATH 67 0.0001
866 HYPERHIDROSIS 10 0.0001
867 ANAPHYLACTIC SHOCK 2 0.0001
868 RHINORRHOEA 5 0.0001
869 HAEMATOMA 2 0.0001
870 PLASMA CELL MYELOMA 3 0.0001
871 RESPIRATORY TRACT INFECTION 2 0.0001
872 CEREBROVASCULAR ACCIDENT 13 0.0001
873 FEELING ABNORMAL 18 0.0001
874 DYSPHAGIA 7 0.0001
875 INFLUENZA LIKE ILLNESS 6 0.0001
876 VISION BLURRED 10 0.0001
877 VISUAL IMPAIRMENT 9 0.0001
878 FEELING COLD 2 0.0001
879 APHONIA 1 0.0001
880 EYE PAIN 4 0.0001
881 BRONCHOSPASM 1 0.0001
882 HYPERSOMNIA 2 0.0001
883 HERPES ZOSTER 4 0.0001
884 ACCIDENTAL UNDERDOSE 1 0.0001
885 BLOOD CREATINE PHOSPHOKINASE INCREASED 2 0.0001
886 BLOOD GLUCOSE INCREASED 13 0.0001
887 DISEASE PROGRESSION 8 0.0001
888 URINARY INCONTINENCE 2 0.0001
889 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
890 DEHYDRATION 9 0.0001
891 CATARACT 4 0.0001
892 HAEMORRHAGE 7 0.0001
893 APHASIA 2 0.0001
894 PLATELET COUNT DECREASED 7 0.0001
895 FEELING HOT 4 0.0001
896 ANKLE FRACTURE 1 0.0001
897 DELUSION 1 0.0001
898 OCULAR HYPERAEMIA 3 0.0001
899 MOOD SWINGS 2 0.0001
900 INJECTION SITE BRUISING 5 0.0001
901 HYPOTHYROIDISM 2 0.0001
902 METABOLIC ACIDOSIS 2 0.0001
903 HIP FRACTURE 2 0.0001
904 DRY EYE 3 0.0001
905 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
906 BLOOD UREA INCREASED 1 0.0001
907 CHILLS 7 0.0001
908 EYE PRURITUS 2 0.0001
909 URINARY TRACT INFECTION 10 0.0001
910 GASTRIC DISORDER 2 0.0001
911 DEVICE DEFECTIVE 1 0.0001
912 RASH MACULAR 2 0.0001
913 DEPRESSED MOOD 3 0.0001
914 DRUG INTERACTION 9 0.0001
915 DISTURBANCE IN ATTENTION 3 0.0001
916 DRUG EFFECT INCOMPLETE 2 0.0001
917 PANIC ATTACK 2 0.0001
918 TREATMENT NONCOMPLIANCE 3 0.0001
919 SUICIDAL IDEATION 5 0.0001
920 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 11 0.0001
921 BLOOD GLUCOSE ABNORMAL 1 0.0001
922 CONJUNCTIVITIS 1 0.0001
923 AGRANULOCYTOSIS 1 0.0001
924 HALLUCINATION 4 0.0001
925 HOT FLUSH 4 0.0001
926 BLOOD URINE PRESENT 1 0.0001
927 OVERDOSE 11 0.0001
928 DISORIENTATION 2 0.0001
929 IRRITABILITY 3 0.0000
930 BONE MARROW FAILURE 1 0.0000
931 DERMATITIS 1 0.0000
932 SKIN EXFOLIATION 4 0.0000
933 INTENTIONAL OVERDOSE 3 0.0000
934 VAGINAL HAEMORRHAGE 2 0.0000
935 DEVICE DISLOCATION 2 0.0000
936 DRY SKIN 6 0.0000
937 PULMONARY OEDEMA 2 0.0000
938 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
939 THROAT IRRITATION 2 0.0000
940 CHROMATURIA 1 0.0000
941 NO ADVERSE EVENT 8 0.0000
942 INJECTION SITE REACTION 3 0.0000
943 SEIZURE 5 0.0000
944 RENAL DISORDER 2 0.0000
945 CARDIAC DISORDER 4 0.0000
946 DISEASE RECURRENCE 2 0.0000
947 RASH ERYTHEMATOUS 2 0.0000
948 DIABETIC KETOACIDOSIS 1 0.0000
949 AGITATION 3 0.0000
950 ABASIA 1 0.0000
951 CELLULITIS 2 0.0000
952 ACNE 3 0.0000
953 ABDOMINAL PAIN LOWER 1 0.0000
954 THERAPY CESSATION 2 0.0000
955 DIPLOPIA 1 0.0000
956 DEAFNESS 1 0.0000
957 ANHEDONIA 1 0.0000
958 BRADYCARDIA 2 0.0000
959 BREAST CANCER FEMALE 1 0.0000
960 CARDIAC FAILURE CONGESTIVE 3 0.0000
961 WHITE BLOOD CELL COUNT DECREASED 4 0.0000
962 DEMENTIA 1 0.0000
963 ANGINA PECTORIS 1 0.0000
964 EYE IRRITATION 2 0.0000
965 PRODUCT SUBSTITUTION ISSUE 2 0.0000
966 ACUTE MYOCARDIAL INFARCTION 1 0.0000
967 DEVICE ISSUE 3 0.0000
968 BLOOD PRESSURE DECREASED 2 0.0000
969 NEOPLASM MALIGNANT 2 0.0000
970 INJECTION SITE PRURITUS 2 0.0000
971 TOXICITY TO VARIOUS AGENTS 5 0.0000
972 ANGER 1 0.0000
973 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
974 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
975 RESPIRATORY FAILURE 2 0.0000
976 ABNORMAL BEHAVIOUR 1 0.0000
977 INJECTION SITE HAEMORRHAGE 2 0.0000
978 PROSTATE CANCER 2 0.0000
979 DEVICE LEAKAGE 1 0.0000
980 INJECTION SITE PAIN 7 0.0000
981 INCORRECT DOSE ADMINISTERED 5 0.0000
982 AGGRESSION 1 0.0000
983 CHEST DISCOMFORT 2 0.0000
984 ACCIDENTAL EXPOSURE TO PRODUCT 2 0.0000
985 MYOCARDIAL INFARCTION 3 0.0000
986 EMOTIONAL DISTRESS 2 0.0000
987 INJECTION SITE ERYTHEMA 2 0.0000
988 DEVICE EXPULSION 1 0.0000
989 DEVICE MALFUNCTION 1 0.0000
990 DRUG DEPENDENCE 2 0.0000
991 CARDIAC ARREST 1 0.0000
992 DRUG DOSE OMISSION 2 0.0000